Condensed Consolidated Statements of Income [Abstract] | |
Revenue | 1B |
Cost of sales | 336.94M |
Gross margin | 666.69M |
Operating expenses: | |
Research and development | 172.93M |
Selling, marketing, general and administrative | 118.88M |
Special charge | |
Operating expenses | 309.71M |
Operating income from continuing operations | 356.98M |
Nonoperating (income) expense: | |
Interest expense | 38.76M |
Interest income | -7.11M |
Other, net | 1.9M |
Nonoperating (income) expense | 33.55M |
Income from continuing operations before income taxes | 323.43M |
Provision for income taxes | 27.28M |
Income from continuing operations, net of tax | |
Gain on sale of discontinued operations, net of tax | |
Net income | 296.16M |
Shares used to compute earnings per share - basic | -618.36M |
Shares used to compute earnings per share - diluted | -625.29M |
Basic earnings per share from continuing operations | |
Basic earnings per share | |
Diluted earnings per share from continuing operations | |
Diluted earnings per share | |
Dividends declared and paid per share | 0.42 |
Cost of sales [Member] | |
Includes stock-based compensation expense as follows: | |
Stock-based compensation expense | 1.89M |
Research and development [Member] | |
Includes stock-based compensation expense as follows: | |
Stock-based compensation expense | 7.01M |
Selling, marketing, general and administrative [Member] | |
Includes stock-based compensation expense as follows: | |
Stock-based compensation expense | 6.34M |